Efficacy and Safety of PA32540 (Enteric-coated Aspirin 325 mg and Immediate-release Omeprazole 40 mg) in Patients With a History of Myocardial Infarction: Analyses From Two Phase 3 Clinical Trials

被引：0
|
作者：
Gurbel, Paul
Barish, Charles
Fort, John G.
Koren, Michael
McKenzie, Marcus
Tursi, James P.
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Aspirin; Cardioprotective drugs; Clinical trials; Myocardial infarction;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16722
引用
收藏
页数：7
相关论文
共 13 条
  • [1] Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325mg+immediate-release omeprazole 40mg) or enteric-coated aspirin 325mg+enteric-coated omeprazole 40mg-a randomised, phase 1, crossover study
    Miner, P. B., Jr.
    Fort, J. G.
    Zhang, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (01) : 62 - 71
  • [2] Long-Term Safety of PA32540, a Coordinated Delivery Tablet of 325 mg of Enteric-Coated Aspirin and 40 mg of Immediate-Release Omeprazole in Secondary Cardiovascular Patients at Risk for Gastrointestinal Events
    Goldstein, Jay
    Scheiman, James
    Cryer, Byron
    Eisen, Glenn
    Lanas, Angel
    Zhang, Ying
    Fort, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S4 - S4
  • [3] PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: Results of two 6-month, phase 3 studies
    Whellan, David J.
    Goldstein, Jay L.
    Cryer, Byron L.
    Eisen, Glenn M.
    Lanas, Angel
    Miller, Alan B.
    Scheiman, James M.
    Fort, John G.
    Zhang, Ying
    O'Connor, Christopher
    AMERICAN HEART JOURNAL, 2014, 168 (04) : 495 - +
  • [4] PA32540 (Enteric-Coated Aspirin 325 mg + Immediate-Release Omeprazole 40 mg) Is Associated with Significantly Fewer Gastric Ulcers and Significantly Less Endoscopic Erosive Esophagitis than Enteric-Coated Aspirin (EC-ASA) Alone: Results of Two Phase 3 studies
    Goldstein, Jay
    Cryer, Byron
    Lanas, Angel
    Eisen, Glenn
    Scheiman, James
    Zhang, Ying
    Fort, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S53 - S54
  • [5] Combined Results of Two Phase 3 Studies of PA32540, an Antiplatelet Therapy of Enteric-Coated Aspirin and Immediate-Release Omeprazole, in Patients with Previous Cerebrovascular Disease
    Alberts, Mark J.
    Goldstein, Jay L.
    Whellan, David J.
    Fort, John G.
    Zhang, Ying
    STROKE, 2013, 44 (02)
  • [6] PA32540, a Tablet Containing Enteric-Coated (EC) Aspirin 325 mg and Unbuffered Immediate-Release Omeprazole 40 mg, Provides Percent Time Gastric pH >4 Significantly Less Than EC Omeprazole 40 mg, but With Faster Onset and Less Exposure to Omeprazole
    Miner, Philip B.
    Fort, John G.
    Zhang, Ying
    GASTROENTEROLOGY, 2012, 142 (05) : S3 - S3
  • [7] The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events
    Zhang, Wenjie
    Han, Yi
    Fort, John G.
    Schofield, David
    Tursi, James P.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (06) : 592 - 598
  • [8] Efficacy and Safety of PA, a Novel Combination of Enteric-Coated Aspirin and Immediate-Release Omeprazole.
    Alberts, Mark J.
    Fort, John
    Orlemans, Eric
    Unal, Cemal
    Platechetka, John
    STROKE, 2009, 40 (04) : E270 - E270
  • [9] Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, a Tablet With Enteric-coated Aspirin and Immediate-release Omeprazole: Results of Two 6-month, Phase 3 Studies
    Whellan, David J.
    Goldstein, Jay L.
    Scheiman, James M.
    Miller, Alan B.
    Fort, John G.
    Zhang, Ying
    O'Connor, Christopher
    CIRCULATION, 2012, 126 (21)
  • [10] PA32520 (single-tablet of immediate-release omeprazole 20 mg + enteric-coated aspirin 325 mg): safer aspirin therapy with greater thromboxane suppression
    Gurbel, P. A.
    Fort, J. G.
    Orlemans, E.
    Planchetka, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 901 - 901
12